- Home
- BMRN vs ROKU Comparison
BMRN vs ROKU Comparison
Compare BMRN & ROKU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- ROKU
- Stock Information
- Founded
- BMRN 1996
- ROKU 2002
- Country
- BMRN United States
- ROKU United States
- Employees
- BMRN N/A
- ROKU N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- ROKU Cable & Other Pay Television Services
- Sector
- BMRN Health Care
- ROKU Telecommunications
- Exchange
- BMRN Nasdaq
- ROKU Nasdaq
- Market Cap
- BMRN 12.1B
- ROKU 11.9B
- IPO Year
- BMRN 1999
- ROKU 2017
- Fundamental
- Price
- BMRN $59.01
- ROKU $90.12
- Analyst Decision
- BMRN Buy
- ROKU Buy
- Analyst Count
- BMRN 23
- ROKU 24
- Target Price
- BMRN $93.73
- ROKU $93.88
- AVG Volume (30 Days)
- BMRN 1.8M
- ROKU 2.6M
- Earning Date
- BMRN 08-04-2025
- ROKU 07-31-2025
- Dividend Yield
- BMRN N/A
- ROKU N/A
- EPS Growth
- BMRN 152.82
- ROKU N/A
- EPS
- BMRN 2.71
- ROKU N/A
- Revenue
- BMRN $2,950,227,000.00
- ROKU $4,252,100,999.00
- Revenue This Year
- BMRN $12.27
- ROKU $12.99
- Revenue Next Year
- BMRN $9.99
- ROKU $11.92
- P/E Ratio
- BMRN $21.81
- ROKU N/A
- Revenue Growth
- BMRN 19.36
- ROKU 17.30
- 52 Week Low
- BMRN $52.93
- ROKU $48.33
- 52 Week High
- BMRN $94.85
- ROKU $104.96
- Technical
- Relative Strength Index (RSI)
- BMRN 55.66
- ROKU 60.79
- Support Level
- BMRN $56.48
- ROKU $88.21
- Resistance Level
- BMRN $60.43
- ROKU $91.20
- Average True Range (ATR)
- BMRN 1.52
- ROKU 2.31
- MACD
- BMRN 0.23
- ROKU -0.54
- Stochastic Oscillator
- BMRN 64.05
- ROKU 36.84
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About ROKU Roku Inc.
Roku enables consumers to stream television programming. It has more than 90 million streaming households and provided 127 billion streaming hours in 2024. Roku is the top streaming operating system in the US, reaching more than half of broadband households, according to the company. Roku's OS is built into streaming devices and televisions that Roku sells and on connected televisions from other manufacturers that license Roku's name and software. Roku also operates the Roku Channel, a free, ad-supported streaming television platform that offers a mix of on-demand and live television programming. Roku generates revenue primarily from selling devices, licensing, and advertising, and it receives fees from subscription streaming platforms that sell subscriptions through Roku.